APO Research
Talk to an analyst

APO RESEARCH · REPORT

Musculoskeletal System Disorder Therapeutics

Compare research editions
View pricing & licenses

Selected research

Industry Research

Musculoskeletal System Disorder Therapeutics Industry Research Report 2026

28 December 2025140 pages

Choose your research edition.

Industry ResearchMusculoskeletal System Disorder Therapeutics Industry Research Report 2026140 pages · $2,950 USDIndustry Growth & TrendsGlobal Musculoskeletal System Disorder Therapeutics Industry Growth and Trends Forecast to 2032124 pages · $3,450 USDMarket StructureGlobal Musculoskeletal System Disorder Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Musculoskeletal System Disorder Therapeutics Market Outlook and Growth Opportunities 2026219 pages · $4,250 USDMarket Analysis & ForecastGlobal Musculoskeletal System Disorder Therapeutics Market Analysis and Forecast 2026-2032219 pages · $4,950 USD

Market perspective

The global Musculoskeletal System Disorder Therapeutics market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

North America: the Musculoskeletal System Disorder Therapeutics market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Musculoskeletal System Disorder Therapeutics market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Musculoskeletal System Disorder Therapeutics market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Musculoskeletal System Disorder Therapeutics include Acumed, Amgen, Asahi Kasei, Astellas Pharma, B Braun, Cadila Healthcare, Eli Lilly, GSK and Nippon Shinyaku, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

Read the full market overview

This report quantifies the global Musculoskeletal System Disorder Therapeutics market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Musculoskeletal System Disorder Therapeutics.

Key Companies & Market Share Insights

This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Musculoskeletal System Disorder Therapeutics Market by Company

Acumed

Amgen

Asahi Kasei

Astellas Pharma

B Braun

Cadila Healthcare

Eli Lilly

GSK

Nippon Shinyaku

Orthofix

OsteoMed

Smith & Nephew

Stryker

Torrent Pharmaceuticals

Wright Medical

Zimmer Biomet

AbbVie

Bayer

Pfizer

Merck & Co

Novartis

Johnson & Johnson

Sanofi

Eisai

Abbott

Musculoskeletal System Disorder Therapeutics Segment by Type

Muscle Disorder

Joint Disorder

Bone Disorder

Other

Musculoskeletal System Disorder Therapeutics Segment by Application

Hospital & Clinic

Retail Pharmacy

Other

Musculoskeletal System Disorder Therapeutics Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Spain

Russia

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Saudi Arabia

Israel

United Arab Emirates

Turkey

Iran

Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Musculoskeletal System Disorder Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Musculoskeletal System Disorder Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Musculoskeletal System Disorder Therapeutics.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 6: Detailed analysis of Musculoskeletal System Disorder Therapeutics companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 13: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Musculoskeletal System Disorder Therapeutics Market Size by Type (2021-2026) & (US$ Million) Table 6. Global Musculoskeletal System Disorder Therapeutics Revenue Market Share by Type (2021-2026) Table 7. Global Musculoskeletal System Disorder Therapeutics Forecasted Market Size by Type (2027-2032) & (US$ Million) Table 8. Global Musculoskeletal System Disorder Therapeutics Revenue Market Share by Type (2027-2032) Table 9. Global Musculoskeletal System Disorder Therapeutics Market Size by Application (2021-2026) & (US$ Million) Table 10. Global Musculoskeletal System Disorder Therapeutics Revenue Market Share by Application (2021-2026) Table 11. Global Musculoskeletal System Disorder Therapeutics Forecasted Market Size by Application (2027-2032) & (US$ Million) Table 12. Global Musculoskeletal System Disorder Therapeutics Revenue Market Share by Application (2027-2032) Table 13. Global Musculoskeletal System Disorder Therapeutics Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 14. Global Musculoskeletal System Disorder Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 15. Global Musculoskeletal System Disorder Therapeutics Market Share by Region (2021-2026) Table 16. Global Musculoskeletal System Disorder Therapeutics Forecasted Market Size by Region (2027-2032) & (US$ Million) Table 17. Global Musculoskeletal System Disorder Therapeutics Market Share by Region (2027-2032) Table 18. Musculoskeletal System Disorder Therapeutics Industry Trends Table 19. Musculoskeletal System Disorder Therapeutics Industry Drivers Table 20. Musculoskeletal System Disorder Therapeutics Industry Opportunities and Challenges Table 21. Musculoskeletal System Disorder Therapeutics Market Restraints Table 22. Global Top Musculoskeletal System Disorder Therapeutics Players by Revenue (US$ Million) & (2021-2026) Table 23. Global Musculoskeletal System Disorder Therapeutics Revenue Market Share by Players (2021-2026) Table 24. Global Musculoskeletal System Disorder Therapeutics Industry Players Ranking, 2024 VS 2025 VS 2026 Table 25. Global Key Players of Musculoskeletal System Disorder Therapeutics, Headquarters and Area Served Table 26. Global Musculoskeletal System Disorder Therapeutics Players, Product Type & Application Table 27. Global Players Market Concentration Ratio (CR5 and HHI) Table 28. Global Musculoskeletal System Disorder Therapeutics by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 29. Players Mergers & Acquisitions, Expansion Plans Table 30. North America Musculoskeletal System Disorder Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 31. North America Musculoskeletal System Disorder Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 32. North America Musculoskeletal System Disorder Therapeutics Market Size by Country (2027-2032) & (US$ Million) Table 33. Europe Musculoskeletal System Disorder Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Europe Musculoskeletal System Disorder Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 35. Europe Musculoskeletal System Disorder Therapeutics Market Size by Country (2027-2032) & (US$ Million) Table 36. Asia Pacific Musculoskeletal System Disorder Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 37. Asia Pacific Musculoskeletal System Disorder Therapeutics Market Size by Region (2021-2026) & (US$ Million) Table 38. Asia Pacific Musculoskeletal System Disorder Therapeutics Market Size by Country (2027-2032) & (US$ Million) Table 39. South America Musculoskeletal System Disorder Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. South America Musculoskeletal System Disorder Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 41. South America Musculoskeletal System Disorder Therapeutics Market Size by Country (2027-2032) & (US$ Million) Table 42. Middle East & Africa Musculoskeletal System Disorder Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 43. Middle East & Africa Musculoskeletal System Disorder Therapeutics Market Size by Country (2021-2026) & (US$ Million) Table 44. Middle East & Africa Musculoskeletal System Disorder Therapeutics Market Size by Country (2027-2032) & (US$ Million) Table 45. Acumed Company Information Table 46. Acumed Business Overview Table 47. Acumed Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 48. Acumed Musculoskeletal System Disorder Therapeutics Product Portfolio Table 49. Acumed Recent Developments Table 50. Amgen Company Information Table 51. Amgen Business Overview Table 52. Amgen Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 53. Amgen Musculoskeletal System Disorder Therapeutics Product Portfolio Table 54. Amgen Recent Developments Table 55. Asahi Kasei Company Information Table 56. Asahi Kasei Business Overview Table 57. Asahi Kasei Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 58. Asahi Kasei Musculoskeletal System Disorder Therapeutics Product Portfolio Table 59. Asahi Kasei Recent Developments Table 60. Astellas Pharma Company Information Table 61. Astellas Pharma Business Overview Table 62. Astellas Pharma Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 63. Astellas Pharma Musculoskeletal System Disorder Therapeutics Product Portfolio Table 64. Astellas Pharma Recent Developments Table 65. B Braun Company Information Table 66. B Braun Business Overview Table 67. B Braun Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 68. B Braun Musculoskeletal System Disorder Therapeutics Product Portfolio Table 69. B Braun Recent Developments Table 70. Cadila Healthcare Company Information Table 71. Cadila Healthcare Business Overview Table 72. Cadila Healthcare Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 73. Cadila Healthcare Musculoskeletal System Disorder Therapeutics Product Portfolio Table 74. Cadila Healthcare Recent Developments Table 75. Eli Lilly Company Information Table 76. Eli Lilly Business Overview Table 77. Eli Lilly Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 78. Eli Lilly Musculoskeletal System Disorder Therapeutics Product Portfolio Table 79. Eli Lilly Recent Developments Table 80. GSK Company Information Table 81. GSK Business Overview Table 82. GSK Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 83. GSK Musculoskeletal System Disorder Therapeutics Product Portfolio Table 84. GSK Recent Developments Table 85. Nippon Shinyaku Company Information Table 86. Nippon Shinyaku Business Overview Table 87. Nippon Shinyaku Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 88. Nippon Shinyaku Musculoskeletal System Disorder Therapeutics Product Portfolio Table 89. Nippon Shinyaku Recent Developments Table 90. Orthofix Company Information Table 91. Orthofix Business Overview Table 92. Orthofix Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 93. Orthofix Musculoskeletal System Disorder Therapeutics Product Portfolio Table 94. Orthofix Recent Developments Table 95. OsteoMed Company Information Table 96. OsteoMed Business Overview Table 97. OsteoMed Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 98. OsteoMed Musculoskeletal System Disorder Therapeutics Product Portfolio Table 99. OsteoMed Recent Developments Table 100. Smith & Nephew Company Information Table 101. Smith & Nephew Business Overview Table 102. Smith & Nephew Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 103. Smith & Nephew Musculoskeletal System Disorder Therapeutics Product Portfolio Table 104. Smith & Nephew Recent Developments Table 105. Stryker Company Information Table 106. Stryker Business Overview Table 107. Stryker Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 108. Stryker Musculoskeletal System Disorder Therapeutics Product Portfolio Table 109. Stryker Recent Developments Table 110. Torrent Pharmaceuticals Company Information Table 111. Torrent Pharmaceuticals Business Overview Table 112. Torrent Pharmaceuticals Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 113. Torrent Pharmaceuticals Musculoskeletal System Disorder Therapeutics Product Portfolio Table 114. Torrent Pharmaceuticals Recent Developments Table 115. Wright Medical Company Information Table 116. Wright Medical Business Overview Table 117. Wright Medical Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 118. Wright Medical Musculoskeletal System Disorder Therapeutics Product Portfolio Table 119. Wright Medical Recent Developments Table 120. Zimmer Biomet Company Information Table 121. Zimmer Biomet Business Overview Table 122. Zimmer Biomet Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 123. Zimmer Biomet Musculoskeletal System Disorder Therapeutics Product Portfolio Table 124. Zimmer Biomet Recent Developments Table 125. AbbVie Company Information Table 126. AbbVie Business Overview Table 127. AbbVie Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 128. AbbVie Musculoskeletal System Disorder Therapeutics Product Portfolio Table 129. AbbVie Recent Developments Table 130. Bayer Company Information Table 131. Bayer Business Overview Table 132. Bayer Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 133. Bayer Musculoskeletal System Disorder Therapeutics Product Portfolio Table 134. Bayer Recent Developments Table 135. Pfizer Company Information Table 136. Pfizer Business Overview Table 137. Pfizer Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 138. Pfizer Musculoskeletal System Disorder Therapeutics Product Portfolio Table 139. Pfizer Recent Developments Table 140. Merck & Co Company Information Table 141. Merck & Co Business Overview Table 142. Merck & Co Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 143. Merck & Co Musculoskeletal System Disorder Therapeutics Product Portfolio Table 144. Merck & Co Recent Developments Table 145. Novartis Company Information Table 146. Novartis Business Overview Table 147. Novartis Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 148. Novartis Musculoskeletal System Disorder Therapeutics Product Portfolio Table 149. Novartis Recent Developments Table 150. Johnson & Johnson Company Information Table 151. Johnson & Johnson Business Overview Table 152. Johnson & Johnson Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 153. Johnson & Johnson Musculoskeletal System Disorder Therapeutics Product Portfolio Table 154. Johnson & Johnson Recent Developments Table 155. Sanofi Company Information Table 156. Sanofi Business Overview Table 157. Sanofi Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 158. Sanofi Musculoskeletal System Disorder Therapeutics Product Portfolio Table 159. Sanofi Recent Developments Table 160. Eisai Company Information Table 161. Eisai Business Overview Table 162. Eisai Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 163. Eisai Musculoskeletal System Disorder Therapeutics Product Portfolio Table 164. Eisai Recent Developments Table 165. Abbott Company Information Table 166. Abbott Business Overview Table 167. Abbott Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026) & (US$ Million) Table 168. Abbott Musculoskeletal System Disorder Therapeutics Product Portfolio Table 169. Abbott Recent Developments Table 170. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Musculoskeletal System Disorder Therapeutics Product Image Figure 5. Global Musculoskeletal System Disorder Therapeutics Market Size Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 6. Global Musculoskeletal System Disorder Therapeutics Market Share by Type: 2025 VS 2032 Figure 7. Muscle Disorder Product Figure 8. Joint Disorder Product Figure 9. Bone Disorder Product Figure 10. Other Product Figure 11. Global Musculoskeletal System Disorder Therapeutics Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 12. Global Musculoskeletal System Disorder Therapeutics Market Share by Application: 2025 VS 2032 Figure 13. Hospital & Clinic Product Figure 14. Retail Pharmacy Product Figure 15. Other Product Figure 16. Global Musculoskeletal System Disorder Therapeutics Market Size (US$ Million), Year-over-Year: 2021-2032 Figure 17. Global Musculoskeletal System Disorder Therapeutics Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 18. Global Musculoskeletal System Disorder Therapeutics Market Share by Region: 2025 VS 2032 Figure 19. Global Musculoskeletal System Disorder Therapeutics Market Share by Players in 2025 Figure 20. Global Musculoskeletal System Disorder Therapeutics Manufacturers Established Date Figure 21. Global Top 5 and 10 Musculoskeletal System Disorder Therapeutics Players Market Share by Revenue in 2025 Figure 22. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. North America Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 24. North America Musculoskeletal System Disorder Therapeutics Market Share by Country (2021-2032) Figure 25. United States Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 26. Canada Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Mexico Musculoskeletal System Disorder Therapeutics Market Share by Country (2021-2032) Figure 28. Europe Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Europe Musculoskeletal System Disorder Therapeutics Market Share by Country (2021-2032) Figure 30. Germany Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. France Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 32. U.K. Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Italy Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 34. Spain Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 35. Russia Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 36. Netherlands Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 37. Nordic Countries Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 38. Asia-Pacific Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Musculoskeletal System Disorder Therapeutics Market Share by Country (2021-2032) Figure 40. China Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 41. Japan Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 42. South Korea Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 43. India Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 44. India Musculoskeletal System Disorder Therapeutics Market Share by Country (2021-2032) Figure 45. Australia Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 46. China Taiwan Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 47. Southeast Asia Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 48. South America Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 49. South America Musculoskeletal System Disorder Therapeutics Market Share by Country (2021-2032) Figure 50. Brazil Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 51. Argentina Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 52. Chile Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 53. Colombia Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 54. Peru Musculoskeletal System Disorder Therapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 55. Acumed Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 56. Amgen Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 57. Asahi Kasei Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 58. Astellas Pharma Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 59. B Braun Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 60. Cadila Healthcare Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 61. Eli Lilly Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 62. GSK Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 63. Nippon Shinyaku Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 64. Orthofix Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 65. OsteoMed Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 66. Smith & Nephew Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 67. Stryker Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 68. Torrent Pharmaceuticals Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 69. Wright Medical Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 70. Zimmer Biomet Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 71. AbbVie Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 72. Bayer Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 73. Pfizer Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 74. Merck & Co Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 75. Novartis Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 76. Johnson & Johnson Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 77. Sanofi Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 78. Eisai Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026) Figure 79. Abbott Revenue Growth Rate in Musculoskeletal System Disorder Therapeutics Business (2021-2026)

Scope & coverage.

Types
  • Muscle Disorder
  • Joint Disorder
  • Bone Disorder
  • Other
Applications
  • Hospital & Clinic
  • Retail Pharmacy
  • Other
Companies covered
  • Acumed
  • Amgen
  • Asahi Kasei
  • Astellas Pharma
  • B Braun
  • Cadila Healthcare
  • Eli Lilly
  • GSK
  • Nippon Shinyaku
  • Orthofix
  • OsteoMed
  • Smith & Nephew
  • Stryker
  • Torrent Pharmaceuticals
  • Wright Medical
  • Zimmer Biomet
  • AbbVie
  • Bayer
  • Pfizer
  • Merck & Co
  • Novartis
  • Johnson & Johnson
  • Sanofi
  • Eisai
  • Abbott

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Musculoskeletal System Disorder Therapeutics by Type
  3. 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
  4. 2.2.2 Muscle Disorder
  5. 2.2.3 Joint Disorder
  6. 2.2.4 Bone Disorder
  7. 2.2.5 Other
  8. 2.3 Musculoskeletal System Disorder Therapeutics by Application
  9. 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  10. 2.3.2 Hospital & Clinic
  11. 2.3.3 Retail Pharmacy
  12. 2.3.4 Other
  13. 2.4 Assumptions and Limitations
3 Musculoskeletal System Disorder Therapeutics Breakdown Data by Type
  1. 3.1 Global Musculoskeletal System Disorder Therapeutics Historic Market Size by Type (2021-2026)
  2. 3.2 Global Musculoskeletal System Disorder Therapeutics Forecasted Market Size by Type (2027-2032)
4 Musculoskeletal System Disorder Therapeutics Breakdown Data by Application
  1. 4.1 Global Musculoskeletal System Disorder Therapeutics Historic Market Size by Application (2021-2026)
  2. 4.2 Global Musculoskeletal System Disorder Therapeutics Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
  1. 5.1 Global Musculoskeletal System Disorder Therapeutics Market Perspective (2021-2032)
  2. 5.2 Global Musculoskeletal System Disorder Therapeutics Growth Trends by Region
  3. 5.2.1 Global Musculoskeletal System Disorder Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
  4. 5.2.2 Musculoskeletal System Disorder Therapeutics Historic Market Size by Region (2021-2026)
  5. 5.2.3 Musculoskeletal System Disorder Therapeutics Forecasted Market Size by Region (2027-2032)
  6. 5.3 Musculoskeletal System Disorder Therapeutics Market Dynamics
  7. 5.3.1 Musculoskeletal System Disorder Therapeutics Industry Trends
  8. 5.3.2 Musculoskeletal System Disorder Therapeutics Market Drivers
  9. 5.3.3 Musculoskeletal System Disorder Therapeutics Market Challenges
  10. 5.3.4 Musculoskeletal System Disorder Therapeutics Market Restraints
6 Market Competitive Landscape by Players
  1. 6.1 Global Top Musculoskeletal System Disorder Therapeutics Players by Revenue
  2. 6.1.1 Global Top Musculoskeletal System Disorder Therapeutics Players by Revenue (2021-2026)
  3. 6.1.2 Global Musculoskeletal System Disorder Therapeutics Revenue Market Share by Players (2021-2026)
  4. 6.2 Global Musculoskeletal System Disorder Therapeutics Industry Players Ranking, 2023 VS 2024 VS 2025
  5. 6.3 Global Key Players of Musculoskeletal System Disorder Therapeutics Head Office and Area Served
  6. 6.4 Global Musculoskeletal System Disorder Therapeutics Players, Product Type & Application
  7. 6.5 Global Musculoskeletal System Disorder Therapeutics Manufacturers Established Date
  8. 6.6 Global Musculoskeletal System Disorder Therapeutics Market CR5 and HHI
  9. 6.7 Global Players Mergers & Acquisition
7 North America
  1. 7.1 North America Musculoskeletal System Disorder Therapeutics Market Size (2021-2032)
  2. 7.2 North America Musculoskeletal System Disorder Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 7.3 North America Musculoskeletal System Disorder Therapeutics Market Size by Country (2021-2026)
  4. 7.4 North America Musculoskeletal System Disorder Therapeutics Market Size by Country (2027-2032)
  5. 7.5 United States
  6. 7.5 United States
  7. 7.6 Canada
  8. 7.7 Mexico
8 Europe
  1. 8.1 Europe Musculoskeletal System Disorder Therapeutics Market Size (2021-2032)
  2. 8.2 Europe Musculoskeletal System Disorder Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 8.3 Europe Musculoskeletal System Disorder Therapeutics Market Size by Country (2021-2026)
  4. 8.4 Europe Musculoskeletal System Disorder Therapeutics Market Size by Country (2027-2032)
  5. 8.5 Germany
  6. 8.6 France
  7. 8.7 U.K.
  8. 8.8 Italy
  9. 8.9 Spain
  10. 8.10 Russia
  11. 8.11 Netherlands
  12. 8.12 Nordic Countries
9 Asia-Pacific
  1. 9.1 Asia-Pacific Musculoskeletal System Disorder Therapeutics Market Size (2021-2032)
  2. 9.2 Asia-Pacific Musculoskeletal System Disorder Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 9.3 Asia-Pacific Musculoskeletal System Disorder Therapeutics Market Size by Country (2021-2026)
  4. 9.4 Asia-Pacific Musculoskeletal System Disorder Therapeutics Market Size by Country (2027-2032)
  5. 9.5 China
  6. 9.6 Japan
  7. 9.7 South Korea
  8. 9.8 India
  9. 9.9 Australia
  10. 9.10 China Taiwan
  11. 9.11 Southeast Asia
10 South America
  1. 10.1 South America Musculoskeletal System Disorder Therapeutics Market Size (2021-2032)
  2. 10.2 South America Musculoskeletal System Disorder Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 10.3 South America Musculoskeletal System Disorder Therapeutics Market Size by Country (2021-2026)
  4. 10.4 South America Musculoskeletal System Disorder Therapeutics Market Size by Country (2027-2032)
  5. 10.5 Brazil
  6. 10.6 Argentina
  7. 10.7 Chile
  8. 10.8 Colombia
  9. 10.9 Peru
11 Middle East & Africa
  1. 11.1 Middle East & Africa Musculoskeletal System Disorder Therapeutics Market Size (2021-2032)
  2. 11.2 Middle East & Africa Musculoskeletal System Disorder Therapeutics Market Growth Rate by Country: 2021 VS 2025 VS 2032
  3. 11.3 Middle East & Africa Musculoskeletal System Disorder Therapeutics Market Size by Country (2021-2026)
  4. 11.4 Middle East & Africa Musculoskeletal System Disorder Therapeutics Market Size by Country (2027-2032)
  5. 11.5 Saudi Arabia
  6. 11.6 Israel
  7. 11.7 United Arab Emirates
  8. 11.8 Turkey
  9. 11.9 Iran
  10. 11.10 Egypt
12 Players Profiled
  1. 12.1 Acumed
  2. 12.1.1 Acumed Company Information
  3. 12.1.2 Acumed Business Overview
  4. 12.1.3 Acumed Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  5. 12.1.4 Acumed Musculoskeletal System Disorder Therapeutics Product Portfolio
  6. 12.1.5 Acumed Recent Developments
  7. 12.2 Amgen
  8. 12.2.1 Amgen Company Information
  9. 12.2.2 Amgen Business Overview
  10. 12.2.3 Amgen Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  11. 12.2.4 Amgen Musculoskeletal System Disorder Therapeutics Product Portfolio
  12. 12.2.5 Amgen Recent Developments
  13. 12.3 Asahi Kasei
  14. 12.3.1 Asahi Kasei Company Information
  15. 12.3.2 Asahi Kasei Business Overview
  16. 12.3.3 Asahi Kasei Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  17. 12.3.4 Asahi Kasei Musculoskeletal System Disorder Therapeutics Product Portfolio
  18. 12.3.5 Asahi Kasei Recent Developments
  19. 12.4 Astellas Pharma
  20. 12.4.1 Astellas Pharma Company Information
  21. 12.4.2 Astellas Pharma Business Overview
  22. 12.4.3 Astellas Pharma Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  23. 12.4.4 Astellas Pharma Musculoskeletal System Disorder Therapeutics Product Portfolio
  24. 12.4.5 Astellas Pharma Recent Developments
  25. 12.5 B Braun
  26. 12.5.1 B Braun Company Information
  27. 12.5.2 B Braun Business Overview
  28. 12.5.3 B Braun Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  29. 12.5.4 B Braun Musculoskeletal System Disorder Therapeutics Product Portfolio
  30. 12.5.5 B Braun Recent Developments
  31. 12.6 Cadila Healthcare
  32. 12.6.1 Cadila Healthcare Company Information
  33. 12.6.2 Cadila Healthcare Business Overview
  34. 12.6.3 Cadila Healthcare Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  35. 12.6.4 Cadila Healthcare Musculoskeletal System Disorder Therapeutics Product Portfolio
  36. 12.6.5 Cadila Healthcare Recent Developments
  37. 12.7 Eli Lilly
  38. 12.7.1 Eli Lilly Company Information
  39. 12.7.2 Eli Lilly Business Overview
  40. 12.7.3 Eli Lilly Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  41. 12.7.4 Eli Lilly Musculoskeletal System Disorder Therapeutics Product Portfolio
  42. 12.7.5 Eli Lilly Recent Developments
  43. 12.8 GSK
  44. 12.8.1 GSK Company Information
  45. 12.8.2 GSK Business Overview
  46. 12.8.3 GSK Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  47. 12.8.4 GSK Musculoskeletal System Disorder Therapeutics Product Portfolio
  48. 12.8.5 GSK Recent Developments
  49. 12.9 Nippon Shinyaku
  50. 12.9.1 Nippon Shinyaku Company Information
  51. 12.9.2 Nippon Shinyaku Business Overview
  52. 12.9.3 Nippon Shinyaku Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  53. 12.9.4 Nippon Shinyaku Musculoskeletal System Disorder Therapeutics Product Portfolio
  54. 12.9.5 Nippon Shinyaku Recent Developments
  55. 12.10 Orthofix
  56. 12.10.1 Orthofix Company Information
  57. 12.10.2 Orthofix Business Overview
  58. 12.10.3 Orthofix Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  59. 12.10.4 Orthofix Musculoskeletal System Disorder Therapeutics Product Portfolio
  60. 12.10.5 Orthofix Recent Developments
  61. 12.11 OsteoMed
  62. 12.11.1 OsteoMed Company Information
  63. 12.11.2 OsteoMed Business Overview
  64. 12.11.3 OsteoMed Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  65. 12.11.4 OsteoMed Musculoskeletal System Disorder Therapeutics Product Portfolio
  66. 12.11.5 OsteoMed Recent Developments
  67. 12.12 Smith & Nephew
  68. 12.12.1 Smith & Nephew Company Information
  69. 12.12.2 Smith & Nephew Business Overview
  70. 12.12.3 Smith & Nephew Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  71. 12.12.4 Smith & Nephew Musculoskeletal System Disorder Therapeutics Product Portfolio
  72. 12.12.5 Smith & Nephew Recent Developments
  73. 12.13 Stryker
  74. 12.13.1 Stryker Company Information
  75. 12.13.2 Stryker Business Overview
  76. 12.13.3 Stryker Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  77. 12.13.4 Stryker Musculoskeletal System Disorder Therapeutics Product Portfolio
  78. 12.13.5 Stryker Recent Developments
  79. 12.14 Torrent Pharmaceuticals
  80. 12.14.1 Torrent Pharmaceuticals Company Information
  81. 12.14.2 Torrent Pharmaceuticals Business Overview
  82. 12.14.3 Torrent Pharmaceuticals Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  83. 12.14.4 Torrent Pharmaceuticals Musculoskeletal System Disorder Therapeutics Product Portfolio
  84. 12.14.5 Torrent Pharmaceuticals Recent Developments
  85. 12.15 Wright Medical
  86. 12.15.1 Wright Medical Company Information
  87. 12.15.2 Wright Medical Business Overview
  88. 12.15.3 Wright Medical Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  89. 12.15.4 Wright Medical Musculoskeletal System Disorder Therapeutics Product Portfolio
  90. 12.15.5 Wright Medical Recent Developments
  91. 12.16 Zimmer Biomet
  92. 12.16.1 Zimmer Biomet Company Information
  93. 12.16.2 Zimmer Biomet Business Overview
  94. 12.16.3 Zimmer Biomet Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  95. 12.16.4 Zimmer Biomet Musculoskeletal System Disorder Therapeutics Product Portfolio
  96. 12.16.5 Zimmer Biomet Recent Developments
  97. 12.17 AbbVie
  98. 12.17.1 AbbVie Company Information
  99. 12.17.2 AbbVie Business Overview
  100. 12.17.3 AbbVie Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  101. 12.17.4 AbbVie Musculoskeletal System Disorder Therapeutics Product Portfolio
  102. 12.17.5 AbbVie Recent Developments
  103. 12.18 Bayer
  104. 12.18.1 Bayer Company Information
  105. 12.18.2 Bayer Business Overview
  106. 12.18.3 Bayer Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  107. 12.18.4 Bayer Musculoskeletal System Disorder Therapeutics Product Portfolio
  108. 12.18.5 Bayer Recent Developments
  109. 12.19 Pfizer
  110. 12.19.1 Pfizer Company Information
  111. 12.19.2 Pfizer Business Overview
  112. 12.19.3 Pfizer Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  113. 12.19.4 Pfizer Musculoskeletal System Disorder Therapeutics Product Portfolio
  114. 12.19.5 Pfizer Recent Developments
  115. 12.20 Merck & Co
  116. 12.20.1 Merck & Co Company Information
  117. 12.20.2 Merck & Co Business Overview
  118. 12.20.3 Merck & Co Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  119. 12.20.4 Merck & Co Musculoskeletal System Disorder Therapeutics Product Portfolio
  120. 12.20.5 Merck & Co Recent Developments
  121. 12.21 Novartis
  122. 12.21.1 Novartis Company Information
  123. 12.21.2 Novartis Business Overview
  124. 12.21.3 Novartis Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  125. 12.21.4 Novartis Musculoskeletal System Disorder Therapeutics Product Portfolio
  126. 12.21.5 Novartis Recent Developments
  127. 12.22 Johnson & Johnson
  128. 12.22.1 Johnson & Johnson Company Information
  129. 12.22.2 Johnson & Johnson Business Overview
  130. 12.22.3 Johnson & Johnson Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  131. 12.22.4 Johnson & Johnson Musculoskeletal System Disorder Therapeutics Product Portfolio
  132. 12.22.5 Johnson & Johnson Recent Developments
  133. 12.23 Sanofi
  134. 12.23.1 Sanofi Company Information
  135. 12.23.2 Sanofi Business Overview
  136. 12.23.3 Sanofi Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  137. 12.23.4 Sanofi Musculoskeletal System Disorder Therapeutics Product Portfolio
  138. 12.23.5 Sanofi Recent Developments
  139. 12.24 Eisai
  140. 12.24.1 Eisai Company Information
  141. 12.24.2 Eisai Business Overview
  142. 12.24.3 Eisai Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  143. 12.24.4 Eisai Musculoskeletal System Disorder Therapeutics Product Portfolio
  144. 12.24.5 Eisai Recent Developments
  145. 12.25 Abbott
  146. 12.25.1 Abbott Company Information
  147. 12.25.2 Abbott Business Overview
  148. 12.25.3 Abbott Revenue in Musculoskeletal System Disorder Therapeutics Business (2021-2026)
  149. 12.25.4 Abbott Musculoskeletal System Disorder Therapeutics Product Portfolio
  150. 12.25.5 Abbott Recent Developments
13 Report Conclusion
    14 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst